Spring 13, Week 8: Share Practice

SharePractice Logotype_Mark_Vertical.jpeg

“Experience, not knowledge, is the biggest limiting factor between good doctors and great doctors.” This week we hear from Dr. Andrew Brandeis, of Share Practice.

Good doctors make bad decisions because knowledge sources are broken. Medical reference tools are biased by business and insurance interests and most doctors don’t have time to read antiquated research papers. Doctors are also not aware of new or effective treatments because there are no easy ways for us to disseminate information. So we call, text, and email each other. This is a terrible way to share the most important information in the largest market in the world.

Our mission at Share Practice is to structure the world’s medical information and make it available to doctors everywhere. We’ve created a medical reference that doctors use to collaborate on treatments and diagnostics, and rate clinical efficacy. It gives every doctor the ability to publish findings, get feedback from the community, review conventional therapies and incorporate new findings into the collective knowledge-base through our beautiful iPhone app.

We just got back from an amazing trip to NY where we launched at Tech Crunch Disrupt . We got incredible feedback from a community of entrepreneurs, and the resounding theme we heard was that a mission-driven company like Share Practice is what’s missing from the startup scene today. Due to the outstanding response, we’ve extended our seed round to be able to collaborate with successful investors who want to help us change the world in a big way.

Since our work with investors like Hub Ventures began, we’ve refined our vision and customer segmentation, and recommitted to not being persuaded by business interests that will distract us from our mission.

But starting a company from scratch is tough. Our motivation is imagining what happens when a cardiologist in NY collaborates in real time with a colleague in Zurich, posts his preferred treatments, and gets to influence the treatment a healthcare worker in Uganda delivers. We wonder what will happen when he can give feedback on native treatments used in Africa and share them with practitioners in NY. Imagine that dialogue. Will we find new uses for current treatments? Will we discover new, cheaper therapies? Will medical information continue to be a double blind controlled trial funded by business interests, or become a global conversation? Will a million doctors working together cure HIV? Cancer? Will Share Practice create the first social clinical trials?

What will the world look like when every doctor is a great doctor because he has a million doctors in his practice?